The Claim
Acute exenatide infusion increases urine pH and sodium excretion in overweight adults with and without type 2 diabetes, and these changes are strongly correlated with increased uric acid excretion, suggesting a shared renal tubular mechanism involving inhibition of the Na⁺/H⁺ exchanger type 3.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A single dose of exenatide increases the pH and sodium content of urine in overweight adults, regardless of diabetes status, and this is accompanied by a proportional increase in uric acid excretion, indicating a common kidney tubule process involving the Na⁺/H⁺ exchanger type 3.
See the scientific wording
Acute exenatide infusion increases urine pH and sodium excretion in overweight adults with and without type 2 diabetes, and these changes are strongly correlated with increased uric acid excretion, suggesting a shared renal tubular mechanism involving inhibition of the Na⁺/H⁺ exchanger type 3.
Exenatide binds to receptors in the kidney's filtering tubes, blocking a sodium-hydrogen switch that normally reabsorbs sodium and acid. This causes more sodium and less acid to leave the body in urine. The less acidic urine makes it harder for the kidney to pull uric acid back in, so more uric acid is dumped out too.
What the research says
1 studyWhen exenatide is given by IV, the kidneys dump out more uric acid and sodium, and the urine becomes less acidic — all at the same time. This suggests they’re using the same kidney switch to do all three things.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.